KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-20-1255
Published Online: 2020-11-13
Published Print: 2020-11-15
Update policy: https://doi.org/10.1158/crossmark_policy
Rozeveld, Cody N.
Johnson, Katherine M.
Zhang, Lizhi
Razidlo, Gina L.
Funding for this research was provided by:
Pancreatic Cancer (P50 CA102701)
Mayo Clinic Center (P30 DK084567)
Mayo Clinic Cancer Center (P30 CA015083)
NCI (R01 CA104125)